Results 111 to 120 of about 23,191 (234)

Optimisation of the Danish national haemoglobinopathy screening programme – A prospective intervention study

open access: yeseJHaem, Volume 6, Issue 3, June 2025.
Abstract Introduction The Danish national haemoglobinopathy screening programme offers screening to at‐risk pregnant women. Despite efforts to increase awareness of the screening programme, most women in the target population remain unscreened. In contrast, > 90% of pregnant women in Denmark attend a screening for chromosomal abnormalities by combined ...
Esther Agnethe Ejskjær Gravholt   +6 more
wiley   +1 more source

Incidence of Inborn Errors of Metabolism by Expanded Newborn Screening in a Mexican Hospital

open access: yesJournal of Inborn Errors of Metabolism and Screening, 2016
Newborn screening for the detection of inborn errors of metabolism (IEM), endocrinopathies, hemoglobinopathies, and other disorders is a public health initiative aimed at identifying specific diseases in a timely manner.
Consuelo Cantú-Reyna MD   +6 more
doaj   +1 more source

Depression Screening and Primary Care Engagement and Their Association With Socioeconomic Disadvantage Among Adolescents Aged 13–17 Years With Sickle Cell Disease

open access: yesPediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT It is unclear if adolescents with sickle cell disease (SCD) are screened for depression, since primary care provider (PCP) visits decline with age and socioeconomic disadvantage may impact receipt of care. This 1‐year study identified 97% of adolescents with SCD at Nationwide Children's Hospital (NCH) had a PCP. Among those with an NCH PCP (n =
Anyssa Young   +3 more
wiley   +1 more source

PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE

open access: yesHemaSphere, 2022
Y. Bouchakor Moussa   +8 more
doaj   +1 more source

Comparing Comorbidity Indices to Predict Survival After Pediatric Hematopoietic Stem Cell Transplantation for Nonmalignant Disease

open access: yesPediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Background Hematopoietic stem cell transplantation (HCT) is a potentially curative treatment for children with hematological or immunological disorders. However, treatment‐related morbidity and mortality remain concerning. Various comorbidity indices are currently used to assess the risk of complications following pediatric HCT.
Roos Lotte Alexandra Bukman   +4 more
wiley   +1 more source

Noninvasive Evaluation of Prolonged‐Release Pirfenidone in Compensated Liver Cirrhosis. ODISEA Study, a Randomised Trial

open access: yesLiver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background Advanced liver fibrosis (ALF) predicts an adverse prognosis in chronic liver disease. In addition to etiological treatment, a new approach to stop or reverse residual fibrosis is desirable. Objective To assess the efficacy and safety of prolonged‐release pirfenidone (PR‐PFD) versus placebo in compensated cirrhosis.
Linda E. Muñoz‐Espinosa   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy